Onconova Therapeutics Inc (ONTX)

NASDAQ
0.526
+0.0235(+4.68%)
After Hours
0.5395
+0.0135(+2.5665%)
- Real-time Data
  • Volume:
    4,325,382
  • Bid/Ask:
    0.53/0.539
  • Day's Range:
    0.5115 - 0.5466

ONTX Overview

Prev. Close
0.5025
Day's Range
0.5115 - 0.5466
Revenue
240K
Open
0.5155
52 wk Range
0.1901 - 1.92
EPS
-0.14
Volume
4,325,382
Market Cap
124.46M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
31,309,312
P/E Ratio
-
Beta
1.69
1-Year Change
45.75%
Shares Outstanding
236,612,391
Next Earnings Date
May 17, 2021
What is your sentiment on Onconova Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Onconova Therapeutics Inc News

Onconova Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellSellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Onconova Therapeutics Inc Company Profile

Onconova Therapeutics Inc Company Profile

Employees
11

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Read More
  • 15%+
    0
    • hope for 10$
      1
      • 🚀🚀🚀
        0
        • 🚀🚀🚀🚀
          1
          • 🟢🚀
            1
            • THE WEEK is likely to be PIVOT EMA50. Don't sell ok. Buy while you can!🟢🚀
              2
              • i tell u before ...
                1
                • the strong fall approached
                  1
                  • Buy dormir!
                    0
                    • Escape and selling now quickly
                      1
                      • the price now 0.86
                        1
                        • He fell below the ascending line
                          1
                          • Free fall soon
                            1
                            • This week will be a PIVOT week. The price will potentially be supported between EMA (20) and EMA (50) (weekly averages). The price is extremely competitive ...
                              2
                              • $4
                                1
                                • what going on this week?
                                  0
                                  • 1000% profit ...sell now now now
                                    0
                                    • why?
                                      0
                                  • 🚀🚀🚀
                                    1
                                    • Buying is between today and tomorrow, then it is more expensive.
                                      2
                                      • from stock analysis
                                        1
                                        • ONTX has a current Value of $0.10 per share; compared to a Price of $0.93 per share, this stock is currently overvalued
                                          4
                                          • 🤑
                                            2
                                          • 🚀🚀🚀
                                            2
                                          • And uber?
                                            0
                                        • I'm out. I was hoping this would pop last week, but didn't. I read through the paperwork for the upcoming meeting. I feel very confident they will split shares. Best of luck to you all.
                                          1
                                          • Onconova Spikes On Reddit Interest: Shares of clinical-stage biopharma Onconova, which focuses on developing therapies for cancer, are advancing amid a lack of any major company-specific or external catalysts. The shares are getting a lift from stock pumping by Reddit traders, who have vowed to support undervalued biotech stocks with heavy short interest. The penny stock jumped sharply in February amid the r/WallStreetBets trading frenzy.
                                            1
                                            • what really here happens anybody news ?
                                              0
                                              • why is it going up?
                                                0
                                                • good news
                                                  0
                                                • Stan Bannert what's the news?
                                                  0
                                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.